The global Gonorrhea Diagnostics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report includes an overview of the development of the Gonorrhea Diagnostics industry chain, the market status of Hospitals (Chromatography, Diagnostic Imaging), Ambulatory Surgical Centers (Chromatography, Diagnostic Imaging), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gonorrhea Diagnostics.
Regionally, the report analyzes the Gonorrhea Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gonorrhea Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gonorrhea Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gonorrhea Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Chromatography, Diagnostic Imaging).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gonorrhea Diagnostics market.
Regional Analysis: The report involves examining the Gonorrhea Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gonorrhea Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gonorrhea Diagnostics:
Company Analysis: Report covers individual Gonorrhea Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gonorrhea Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Gonorrhea Diagnostics. It assesses the current state, advancements, and potential future developments in Gonorrhea Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gonorrhea Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gonorrhea Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chromatography
Diagnostic Imaging
Differential Light Scattering
Flow Cytometry
Gel Microdroplets
Immunoassay
Molecular Diagnostics
Monoclonal Antibodies Test
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Clinics
Others
Market segment by players, this report covers
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
PerkinElmer
Ortho Clinical Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gonorrhea Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gonorrhea Diagnostics, with revenue, gross margin and global market share of Gonorrhea Diagnostics from 2019 to 2024.
Chapter 3, the Gonorrhea Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gonorrhea Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gonorrhea Diagnostics.
Chapter 13, to describe Gonorrhea Diagnostics research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Gonorrhea Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gonorrhea Diagnostics by Type
1.3.1 Overview: Global Gonorrhea Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Gonorrhea Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Chromatography
1.3.4 Diagnostic Imaging
1.3.5 Differential Light Scattering
1.3.6 Flow Cytometry
1.3.7 Gel Microdroplets
1.3.8 Immunoassay
1.3.9 Molecular Diagnostics
1.3.10 Monoclonal Antibodies Test
1.4 Global Gonorrhea Diagnostics Market by Application
1.4.1 Overview: Global Gonorrhea Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Diagnostic Centers
1.4.5 Clinics
1.4.6 Others
1.5 Global Gonorrhea Diagnostics Market Size & Forecast
1.6 Global Gonorrhea Diagnostics Market Size and Forecast by Region
1.6.1 Global Gonorrhea Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Gonorrhea Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Gonorrhea Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Gonorrhea Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Gonorrhea Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Gonorrhea Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Gonorrhea Diagnostics Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Gonorrhea Diagnostics Product and Solutions
2.1.4 Abbott Laboratories Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Gonorrhea Diagnostics Product and Solutions
2.2.4 Beckman Coulter Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics Gonorrhea Diagnostics Product and Solutions
2.3.4 Roche Diagnostics Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche Diagnostics Recent Developments and Future Plans
2.4 Siemens
2.4.1 Siemens Details
2.4.2 Siemens Major Business
2.4.3 Siemens Gonorrhea Diagnostics Product and Solutions
2.4.4 Siemens Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Siemens Recent Developments and Future Plans
2.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
2.5.1 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Details
2.5.2 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Major Business
2.5.3 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Gonorrhea Diagnostics Product and Solutions
2.5.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Developments and Future Plans
2.6 PerkinElmer
2.6.1 PerkinElmer Details
2.6.2 PerkinElmer Major Business
2.6.3 PerkinElmer Gonorrhea Diagnostics Product and Solutions
2.6.4 PerkinElmer Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 PerkinElmer Recent Developments and Future Plans
2.7 Ortho Clinical Diagnostics
2.7.1 Ortho Clinical Diagnostics Details
2.7.2 Ortho Clinical Diagnostics Major Business
2.7.3 Ortho Clinical Diagnostics Gonorrhea Diagnostics Product and Solutions
2.7.4 Ortho Clinical Diagnostics Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gonorrhea Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Gonorrhea Diagnostics by Company Revenue
3.2.2 Top 3 Gonorrhea Diagnostics Players Market Share in 2023
3.2.3 Top 6 Gonorrhea Diagnostics Players Market Share in 2023
3.3 Gonorrhea Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Gonorrhea Diagnostics Market: Region Footprint
3.3.2 Gonorrhea Diagnostics Market: Company Product Type Footprint
3.3.3 Gonorrhea Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Gonorrhea Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Gonorrhea Diagnostics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Gonorrhea Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Gonorrhea Diagnostics Market Forecast by Application (2025-2030)
6 North America
6.1 North America Gonorrhea Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Gonorrhea Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Gonorrhea Diagnostics Market Size by Country
6.3.1 North America Gonorrhea Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Gonorrhea Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Gonorrhea Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Gonorrhea Diagnostics Market Size by Country
7.3.1 Europe Gonorrhea Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Gonorrhea Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Gonorrhea Diagnostics Market Size by Region
8.3.1 Asia-Pacific Gonorrhea Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
9 South America
9.1 South America Gonorrhea Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Gonorrhea Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Gonorrhea Diagnostics Market Size by Country
9.3.1 South America Gonorrhea Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Gonorrhea Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Gonorrhea Diagnostics Market Size by Country
10.3.1 Middle East & Africa Gonorrhea Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Gonorrhea Diagnostics Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Gonorrhea Diagnostics Market Drivers
11.2 Gonorrhea Diagnostics Market Restraints
11.3 Gonorrhea Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Gonorrhea Diagnostics Industry Chain
12.2 Gonorrhea Diagnostics Upstream Analysis
12.3 Gonorrhea Diagnostics Midstream Analysis
12.4 Gonorrhea Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
PerkinElmer
Ortho Clinical Diagnostics
Ìý
Ìý
*If Applicable.
